The impact of current opioid agonist therapy on hepatitis C virus treatment initiation among people who use drugs from in the DAA era: A population-based study

Clicks: 138
ID: 268690
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #544 of 1,084 articles by views in clinical infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,084 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
AbstractBackground. Evidence that opioid agonist therapy (OAT) is associated with increased odds of hepatitis C virus (HCV) treatment initiation among people wh
Reference Key
rclinicalthe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Bartlett, Sofia R;Wong, Stanley;Yu, Amanda;Pearce, Margo;MacIsaac, Julia;Nouch, Susan;Adu, Prince;Wilton, James;Samji, Hasina;Clementi, Emilia;Velasquez, Hector;Jeong, Dahn;Binka, Mawuena;Alvarez, Maria;Wong, Jason;Buxton, Jane;Krajden, Mel;Janjua, Naveed Z;
Journal clinical infectious diseases
Year Year not found
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.